AI assistant
Onconetix, Inc. — Director's Dealing 2022
Aug 23, 2022
35411_dirs_2022-08-22_f8c42fd0-70bf-4c20-8e8d-241a66fe90b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-08-18
Reporting Person: Hernandez Joseph (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-18 | Common Stock | S | 442539 | $4.9551 | Disposed | 2757461 | Direct |
| 2022-08-19 | Common Stock | S | 76841 | $4.2121 | Disposed | 2680620 | Direct |
| 2022-08-22 | Common Stock | S | 30269 | $4.1034 | Disposed | 2650351 | Direct |
Footnotes
F1: The Common Stock reported herein were sold by the reporting person at a high price of $6.21, a low price of $4.16 and an average price of $4.9551 per share of Common Stock. Upon request, the reporting person will provide details of each sale.
F2: The Common Stock reported herein were sold by the reporting person at a high price of $4.71, a low price of $4.05 and an average price of $4.2121 per share of Common Stock. Upon request, the reporting person will provide details of each sale.
F3: The Common Stock reported herein were sold by the reporting person at a high price of $4.22, a low price of $4.05 and an average price of $4.1034 per share of Common Stock. Upon request, the reporting person will provide details of each sale.